Tilray Brands (TLRY) Total Current Liabilities (2017 - 2026)
Tilray Brands (TLRY) reported Total Current Liabilities of $257.5 million for Q1 2026, up 119.69% on a YoY basis from $117.2 million in Q1 2025, and down 0.68% quarter-over-quarter from $259.3 million in Q4 2025.
Tilray Brands (TLRY) Total Current Liabilities (2017 - 2026) Analysis & Trends
Tilray Brands has reported Total Current Liabilities for 10 years, with the latest figure at $257.5 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 119.69% year-over-year to $257.5 million; the trailing twelve-month figure through Feb 2026 stood at $257.5 million (up 119.69% YoY), and the FY2025 full-year result was $280.3 million, down 6.31% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $257.5 million, down from $259.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $537.3 million in Q3 2023, with the low at $117.2 million in Q1 2025.
- Historically, Total Current Liabilities has averaged $322.3 million across 5 years, with a median of $282.4 million in 2022.
- Annual changes were most pronounced in 2025 — Total Current Liabilities tumbled 64.38% — and 2026, when it jumped 119.69%.
- Tilray Brands' Total Current Liabilities stood at $426.5 million in 2022, then decreased by 7.39% to $395.0 million in 2023, then retreated by 29.49% to $278.5 million in 2024, then dropped by 6.9% to $259.3 million in 2025, then decreased by 0.68% to $257.5 million in 2026.
- The last three Total Current Liabilities figures came in at $257.5 million (Q1 2026), $259.3 million (Q4 2025), and $267.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 257.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 257.54 Mn |
| Nov 30, 2025 | 259.32 Mn |
| Aug 31, 2025 | 267.63 Mn |
| May 31, 2025 | 280.30 Mn |
| Feb 28, 2025 | 117.23 Mn |
| Nov 30, 2024 | 278.52 Mn |
| Aug 31, 2024 | 293.55 Mn |
| May 31, 2024 | 299.17 Mn |
| Feb 29, 2024 | 329.10 Mn |
| Nov 30, 2023 | 394.99 Mn |
| Aug 31, 2023 | 537.27 Mn |
| May 31, 2023 | 432.98 Mn |
| Feb 28, 2023 | 469.68 Mn |
| Nov 30, 2022 | 426.51 Mn |
| Aug 31, 2022 | 273.26 Mn |
| May 31, 2022 | 280.34 Mn |
| Feb 28, 2022 | 282.43 Mn |
| Nov 30, 2021 | 314.93 Mn |
| Aug 31, 2021 | 526.83 Mn |
| May 31, 2021 | 401.24 Mn |